TrialBritish journal of clinical pharmacology2006

Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.

Martijn van Doorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.